Abstract:STUDY QUESTION:Is phosphatase of regenerating liver-3 (PRL-3) associated with increased motility of endometriotic cells from endometrioma?SUMMARY ANSWER:Elevated PRL-3 promotes cytoskeleton reorganization, cell migration and invasion of endometrial stromal cells (ESCs) from endometrioma.WHAT IS KNOWN ALREADY:Overexpression of PRL-3 is associated with cancer cell migration, invasion and metastatic phenotype.STUDY DESIGN, SIZE, DURATION:Primary human ESCs were isolated from eutopic endometrium of women without endometriosis (EuCo, n = 10), with histologically proven endometrioma (EuEM, n = 19) and from the cyst wall of ovarian endometriosis (OvEM, n = 26).PARTICIPANTS/MATERIALS, SETTING, METHODS:The expression of PRL-3 in ESCs derived from EuCo, EuEM and OvEM at different phases of menstrual cycle were compared. The protein and mRNA levels of PRL-3 were examined by western blot and RT-qPCR, respectively. ESCs from OvEM were transfected with/without short hairpin RNA (shRNA) or small interfering RNA (siRNA). Additionally, a plasmid-mediated delivery system was used to achieve PRL-3 overexpression in ESCs from EuEM. The cellular distribution of F-actin and α-tubulin were examined by immunocytochemistry. Cell motility was evaluated by a transwell migration/invasion assay.MAIN RESULTS AND THE ROLE OF CHANCE:The protein and mRNA levels of PRL-3 are significantly elevated in ESCs from OvEM compared with EuCo and EuEM. The expression of PRL-3 was not altered between proliferative phase and secretory phase in ESCs from all groups. Knockdown of PRL-3 significantly modified the distribution of F-actin and α-tubulin cytoskeleton, inhibited cell migration and invasion. Endogenous inhibition of PRL-3 attenuated the expression of Ras homolog gene family members A and C (RhoA, RhoC), Rho-associated coiled-coil-containing protein kinase 1 (ROCK1) and matrix metalloproteinase (MMP) 9, but not MMP2 in ESCs from OvEM. Additionally, overexpression of PRL-3 in ESCs from EuEM up-regulates cell migration and invasion, and increases the expression of RhoA, RhoC, ROCK1 and MMP9.LIMITATIONS, REASONS FOR CAUTION:Lack of in vivo animal studies is the major limitation of our report. Our results should be further confirmed in a larger cohort of patients and extended to include eutopic and ectopic endometrium from patients with peritoneal endometriosis at different stages of the disease.WIDER IMPLICATIONS OF THE FINDINGS:Our study describes that elevated expression of PRL-3 contributes to the cell motility of ESCs from endometrioma. The results emphasize the importance of metastatic-related factor PRL-3 in the pathogenesis of endometrioma.STUDY FUNDING/COMPETING INTEREST:This work was supported by National Natural Science Foundation of China (No. 81170546) and Zhejiang Medicine Science and Technology Projects (No. Y13H040003). The authors declare no conflict of interest.

Oestrogen Receptor Alpha Mediates 17 Beta-Estradiol Enhancement Of Ovarian Cancer Cell Motility Through Up-Regulation Of Survivin Expression

Oestrogen receptor α mediates 17β-estradiol enhancement of ovarian cancer cell motility through up-regulation of survivin expression

Role of Estrogen Receptor-Mediated Anti-Tumor Effects in U2OS Cells.

Estrogen receptor β exhibited anti-tumor effects on osteosarcoma cells by regulating integrin, IAP, NF-kB/BCL-2 and PI3K/Akt signal pathway.

The role of estrogen receptor alpha in mediating chemoresistance in breast cancer cells

Elevated Phosphatase of Regenerating Liver 3 (Prl-3) Promotes Cytoskeleton Reorganization, Cell Migration and Invasion in Ectopic Stromal Cells from Endometrioma

Silencing of SRA1 Regulates ER Expression and Attenuates the Growth of Stromal Cells in Ovarian Endometriosis

Lysine-specific Demethylase 1 Mediates Epidermal Growth Factor Signaling to Promote Cell Migration in Ovarian Cancer Cells

Estrogen Stimulates the Invasion of Ovarian Cancer Cells Via Activation of the PI3K/AKT Pathway and Regulation of Its Downstream Targets E-cadherin and Α-Actinin-4

Estrogen enhances the proliferation and migration of ovarian cancer cells by activating transient receptor potential channel C3

17β‐Estradiol via Orai1 activates calcium mobilization to induce cell proliferation in epithelial ovarian cancer

17Β-Oestradiol Activates Proteolysis and Increases Invasion Through Phosphatidylinositol 3-Kinase Pathway in Human Cervical Cancer Cells.

Effects of Oestrogen on Long Noncoding RNA Expression in Oestrogen Receptor Alpha-Positive Ovarian Cancer Cells

[Role of Estrogen Receptor-Related Receptors Alpha, Beta and Gamma in Ovarian Cancer Cells].

Estrogen And Progestin Regulate Hif-1 Alpha Expression In Ovarian Cancer Cell Lines Via The Activation Of Akt Signaling Transduction Pathway

Re-expression of Estrogen Receptor Β Inhibits the Proliferation and Migration of Ovarian Clear Cell Adenocarcinoma Cells

High Oestrogen receptor alpha expression correlates with adverse prognosis and promotes metastasis in colorectal cancer

Estrogen Receptor Alpha Variant Er Alpha 46 Mediates Growth Inhibition and Apoptosis of Human Ht-29 Colon Adenocarcinoma Cells in the Presence of 17 Beta-Oestradiol

17β-Estradiol inhibits oleic acid-induced rat VSMC Proliferation and migration by restoring PGC-1α expression

Role of estrogen receptor-related receptors α, β and γ in ovarian cancer cells

Increased Steroid Receptor RNA Activator Protein (SRAP) Accompanied by Decreased Estrogen Receptor-Beta (Er-Β) Levels During the Malignant Transformation of Endometriosis Associated Ovarian Clear Cell Carcinoma.